L. Tomasoni

Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule.

Vito De Gennaro Colonna, Mauro Bianchi, Valerio Pascale et al. · PubMed · 2009 · 111 citations

Nitric Oxide, Cardiovascular Pharmacology, Pharmacotherapy +20

Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients

Maurizio Turiel, Fabiola Atzeni, L. Tomasoni et al. · Lara D. Veeken · 2009 · 109 citations · Full text

RESEARCH: Effects of Long‐Term Disease‐Modifying Antirheumatic Drugs on Endothelial Function in Patients with Early Rheumatoid Arthritis

M. Turiel, L. Tomasoni, S. Sitia et al. · Cardiovascular Therapeutics · 2010 · 92 citations · Full text

Vascular Disease, Immunology, Early Rheumatoid Arthritis +20

Coronary Flow Reserve and Asymmetric Dimethylarginine Levels: New Measurements for Identifying Subclinical Atherosclerosis in Patients with Psoriatic Arthritis

Fabiola Atzeni, Piercarlo Sarzi‐Puttini, S. Sitia et al. · The Journal of Rheumatology · 2011 · 52 citations · Full text

Detection of preclinical impairment of myocardial function in rheumatoid arthritis patients with short disease duration by speckle tracking echocardiography

S. Sitia, L. Tomasoni, Silvana Cicala et al. · International Journal of Cardiology · 2011 · 50 citations

Rheumatoid Disorder, Rheumatology, Medical Ultrasound +12